VLCC join hands with Korea-based Caregen

Wellness brand VLCC Health Care Ltd has joined hands with South Korea’s biotechnology and R&D brand Caregen Co Ltd to sell the latter’s products.

Its cosmeceutical brands such as Dermaheal, RENOKIN, and DR.CYJ that provide cutting-edge anti-ageing solutions in 25 countries will be sold by VLCC. The business will be run under a JV Company named VLCC Caregen Pvt. Ltd with 50:50 stake, which also has exclusive rights in India and few other countries.

Caregen will also work with VLCC’s R&D team to conduct studies on various new products and innovations while also providing technical support for clinical trials, if required. Under the agreement, VLCC and Caregen will also share technological resources if they decide to use VLCC’s manufacturing facilities.  In that case, VLCC will manufacture the products to sell them at competitive prices in the respective countries.

“Korean people demand perfection, especially when it comes to skincare products, driving innovation in the industry.  With our tie-up with Caregen, we are bringing the best of Korean technology to our customers. Caregen’s products and solutions will complement and enhance our existing portfolio, which comprises of products from India, Malaysia, Singapore and Switzerland,”  says Mukesh Luthra, Chairman, VLCC Group.

Korean skincare products are fast-rising in popularity globally owing to their consistent investments in R&D. Deep-rooted in skincare treatment rituals, Korea provides high-end technology at highly competitive prices.

“We are very proud to be partnering with VLCC. The company is a respected multinational with 25 years of experience in the industry and this collaboration will open up a whole new market for us,” said Yongji Chung, CEO, Caregen Co Ltd. Founded by Vandana Luthra in 1989, VLCC has operations spanning over 300 locations in 143 cities and direct company managed operations in 14 countries, VLCC.